Aventria® Health Group reposted this
October is National Liver Awareness Month and QC-Health wants to acknowledge the tremendous growing burden that chronic liver disease (CLD) and cirrhosis have on patients and their families. • Mortality from CLD is estimated to nearly triple by 2030 (Estes et al, 2018) • The prevalence of CLD and cirrhosis has increased 1.5- to 2-fold over the past 2 decades (Beste et al, 2015; Moon et al; 2019; Orman et al, 2019; Sepanlou et al, 2020). We believe these statistics make the diagnosis and management of CLD and cirrhosis a priority for the health of Americans and they should be treated like other highly prevalent and costly conditions such as diabetes and stroke. CLD and cirrhosis have many causes, including liver cancer, hepatitis, nonalcoholic steatohepatitis (NASH), nonalcoholic fatty liver disease (NAFLD), certain medications, and alcohol abuse. The under diagnosis of these diseases, poor adherence to management guidelines, and subsequent burden should be concerns for everyone. #OctoberIs4Livers #liverhealth #liverawarenessmonth #QCHealth #liverawareness #worldliverday #LiverCancerAwareness Stacey Richter David Dierk